CN101439115B - External-use medicament for empyrosis - Google Patents
External-use medicament for empyrosis Download PDFInfo
- Publication number
- CN101439115B CN101439115B CN200710050535XA CN200710050535A CN101439115B CN 101439115 B CN101439115 B CN 101439115B CN 200710050535X A CN200710050535X A CN 200710050535XA CN 200710050535 A CN200710050535 A CN 200710050535A CN 101439115 B CN101439115 B CN 101439115B
- Authority
- CN
- China
- Prior art keywords
- parts
- simethicone
- medicine
- affected part
- external
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the field of medicine preparation, in particular to en external medicine for treating burn and scald. The active ingredients of the medicine are prepared by the following raw materials according to the weight by parts: 8-10 parts of rhizoma coptidis, 5-7 parts of folium artemisiae argyi, 5-7 parts of orange peel, 5-7 parts of borneol, 10-15 parts of simethicone; the raw materials except simethicone are carefully chosen and cleaned; drug ingredients which do not go mouldy are respectively put in oven, dried in 60 DEG C till water ration is less than 8%, crashed into 200 mesh powder, blended and packed into bags according to the proportion after germicidal treatment. When in use, the powder is adjusted into pasty by simethicone and a definite amount of medicinal ethanol, is directly coated on an affected part or medicinal mucilage gumming, and then is pasted on the affected part. The product is characterized by fast inflammation diminishing, detumescence and analgesic, good ventilation property, and short treatment period without scaring left and toxic side effect.
Description
Technical field: the invention belongs to the medication preparation field, be specifically related to a kind of external-use medicament for empyrosis.
Background technology: the situation of burn and scald usually occurs clinically, and burn and scald not only makes the people extremely feel bad, and as untimely treatment also can stay cicatrix to skin, the Chinese medicine and western medicine of existing treatment burn and scald all has report, but complicated component, take effect slower.
Summary of the invention: the objective of the invention is at existing treatment burn and scald medicine, complicated component, preparation trouble, the slower defective that takes effect, for people provide a kind of make simple, easy to use, curative effect fast, the external-use medicament for empyrosis that has no side effect.
The objective of the invention is to realize by following technical proposals.
External-use medicament for empyrosis of the present invention is characterized in that: its active component is to be prepared from by following materials of weight proportions: 8～10 parts of Rhizoma Coptidis, 5～7 parts of Folium Artemisiae Argyis, 5～7 parts of Fructus Citri tangerinae skins, 5～7 parts of Borneolum Syntheticums, 10～15 parts of dimethicones.
The preparation method of external-use medicament for empyrosis of the present invention is through selected cleaning with above-mentioned raw material except that dimethicone, there is not the medical material that goes mouldy, insert in the baking oven respectively, handle in oven dry below 60 ℃, to moisture content less than 8%, be ground into 200 purpose fine powders, be mixed in proportion after the sterilization treatment and be packaged into bag, reconcile into pasty state with dimethicone and an amount of medical ethanol during use, directly be applied to affected part or be coated in medical viscose glue and stick and be affixed on affected part again and all can.
To be the inventor according to Chinese medical discrimination theoretical and the technical scheme of the science practicality of summing up out in practice in conjunction with secret prescription handed down in the family from generation to generation in the present invention.The technical program is a principal agent with Rhizoma Coptidis, dimethicone, Rhizoma Coptidis nature and flavor hardship wherein, wide spectrum and stronger sterilization functions are arranged, staphylococcus aureus, Streptococcus hemolyticus, anaerobe are all had good inhibitory effect, and have the effect of heat clearing and damp drying, eliminating fire and detoxication; Dimethicone has detumescence, pain relieving, antiinflammatory and promotes the function of skin growth; Fructus Citri tangerinae skin nature and flavor hardship, can promote local blood circulation and have antibacterial ability and analgesic activity, and can accelerate local moisture absorption, promote skin regeneration; Folium Artemisiae Argyi all has inhibition and kill activity to staphylococcus aureus, beta hemolytic streptococcus, escherichia coli, typhoid fever and Salmonella paratyphi, bacillus pyocyaneus; The Borneolum Syntheticum bitter cold can promote neurogliocyte growth staphylococcus aureus, beta hemolytic streptococcus, viridans streptococci are all had good inhibitory effect, and external has the effect of anticorrosion antipruritic, clearing away heat to alleviate pain, anti-inflammation detumescence.The technical program with several Chinese medicine composition with heat-clearing and toxic substances removing, anti-inflammation detumescence, hemostasis and pain-relieving, antibacterial sterilization, removing the necrotic tissue and promoting granulation together, the mutual collaborative effectiveness of performance, through practice find it to the treatment burn and scald have raw material be easy to get, easy to use, the anti-inflammation detumescence analgesia is fast, good permeability, treatment cycle weak point, preventing from scar, the characteristics that have no side effect.
The invention is further illustrated by the following examples, and the present invention is not limited only to described embodiment.
The specific embodiment:
Embodiment one
Get 8 parts of Rhizoma Coptidis, 5 parts of Folium Artemisiae Argyis, 5 parts of Fructus Citri tangerinae skins, 5 parts of Borneolum Syntheticums, 10 parts of dimethicones, with the above-mentioned selected cleaning of raw material process except that dimethicone, there is not the medical material that goes mouldy, insert respectively in the baking oven, handle in oven dry below 60 ℃, to moisture content less than 8%, be ground into 200 purpose fine powders, be mixed in proportion after the sterilization treatment and be packaged into bag, reconcile into pasty state with dimethicone and an amount of medical ethanol during use, directly be applied to affected part or be coated in medical viscose glue and stick and be affixed on affected part again and all can.
Embodiment two
Get 9 parts of Rhizoma Coptidis, 6 parts of Folium Artemisiae Argyis, 6 parts of Fructus Citri tangerinae skins, 6 parts of Borneolum Syntheticums, 12 parts of dimethicones, with the above-mentioned selected cleaning of raw material process except that dimethicone, there is not the medical material that goes mouldy, insert respectively in the baking oven, handle in oven dry below 60 ℃, to moisture content less than 8%, be ground into 200 purpose fine powders, be mixed in proportion after the sterilization treatment and be packaged into bag, reconcile into pasty state with dimethicone and an amount of medical ethanol during use, directly be applied to affected part or be coated in medical viscose glue and stick and be affixed on affected part again and all can.
Embodiment three
Get 10 parts of Rhizoma Coptidis, 7 parts of Folium Artemisiae Argyis, 7 parts of Fructus Citri tangerinae skins, 7 parts of Borneolum Syntheticums, 15 parts of dimethicones, with the above-mentioned selected cleaning of raw material process except that dimethicone, there is not the medical material that goes mouldy, insert respectively in the baking oven, handle in oven dry below 60 ℃, to moisture content less than 8%, be ground into 200 purpose fine powders, be mixed in proportion after the sterilization treatment and be packaged into bag, reconcile into pasty state with dimethicone and an amount of medical ethanol during use, directly be applied to affected part or be coated in medical viscose glue and stick and be affixed on affected part again and all can.
The clinical drug of the embodiment of the invention is applied to nearly 160 person-times of burn and scald patient, and administration time is 1～3 course of treatment, and be 3～7 days each course of treatment, dosage is decided according to the size of burn and scald area, generally medicine is covered the burn and scald face and get final product, state of an illness weight person can be coated with thicker, changes one time medicine in 2～3 days.Cure: for the state of an illness is eliminated substantially; Produce effects: for the state of an illness takes an evident turn for the better; Effectively: for the state of an illness takes a turn for the better to some extent.Its basic condition is listed in table 1.
Table 1 clinical efficacy situation of the present invention
| ? | Cure | Produce effects | Effectively | Invalid | Add up to | Aggregate efficiency % |
| Burn and scald | 93 | ?51 | ?10 | ?4 | ?158 | ?97.5 |
As seen from the table, external-use medicament for empyrosis of the present invention can reach more than 97% the total effective rate of the sick and wounded curative effect of burn and scald.Medicine of the present invention is mainly used in the situation of no skin serious damage, and as red and swollen, foaming, slightly broken skin person is all available.
Claims (1)
1. external-use medicament for empyrosis, it is characterized in that: its active component is to be prepared from by following materials of weight proportions: 8～10 parts of Rhizoma Coptidis, 5～7 parts of Folium Artemisiae Argyis, 5～7 parts of Fructus Citri tangerinae skins, 5～7 parts of Borneolum Syntheticums, 10～15 parts of dimethicones.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200710050535XA CN101439115B (en) | 2007-11-19 | 2007-11-19 | External-use medicament for empyrosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200710050535XA CN101439115B (en) | 2007-11-19 | 2007-11-19 | External-use medicament for empyrosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101439115A CN101439115A (en) | 2009-05-27 |
| CN101439115B true CN101439115B (en) | 2011-07-20 |
Family
ID=40723813
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200710050535XA Expired - Fee Related CN101439115B (en) | 2007-11-19 | 2007-11-19 | External-use medicament for empyrosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101439115B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1191736A (en) * | 1997-02-24 | 1998-09-02 | 李正凡 | Preparation process of medicine for burns and scald |
| CN1086953C (en) * | 1999-04-15 | 2002-07-03 | 崔北双 | Medical oil for treating burn and scald and its preparing process |
| CN1723930A (en) * | 2005-06-13 | 2006-01-25 | 胡新民 | Ointment for treating burns and scald, and its prepn. method |
-
2007
- 2007-11-19 CN CN200710050535XA patent/CN101439115B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1191736A (en) * | 1997-02-24 | 1998-09-02 | 李正凡 | Preparation process of medicine for burns and scald |
| CN1086953C (en) * | 1999-04-15 | 2002-07-03 | 崔北双 | Medical oil for treating burn and scald and its preparing process |
| CN1723930A (en) * | 2005-06-13 | 2006-01-25 | 胡新民 | Ointment for treating burns and scald, and its prepn. method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101439115A (en) | 2009-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105833279B (en) | External-use medicine composition for treating various wound surfaces of skin and preparation method thereof | |
| CN108853312B (en) | Polycinnamic alcohol external gel and preparation method thereof | |
| CN102028793B (en) | Traditional Chinese medicinal composition for treating burns and scalding | |
| CN101703603B (en) | External-use ointment for treating empyrosis and preparation method thereof | |
| CN101011487B (en) | Externally used Chinese patent drug for treating burn and scald and its preparation | |
| CN100420460C (en) | Chinese medicinal compsns. for treating burn and scald, its prepn. and usage | |
| CN102357164B (en) | Medicine composition for clinical care of burns and preparation method thereof | |
| CN101439115B (en) | External-use medicament for empyrosis | |
| CN105381101A (en) | Medicine used for treating burns, scalds and bedsore and preparation method thereof | |
| CN101439137B (en) | External-use Chinese medicinal composition for toothache | |
| CN101690753B (en) | Chinese medicament preparation for treating burn injuries and preparation method thereof | |
| CN102068614A (en) | Traditional Chinese medicine for treatment of burn and scald | |
| CN102068676A (en) | Medicament for treating chilblain | |
| CN104800310A (en) | Chinese medicinal herb burn ointment for external use and preparation method thereof | |
| CN103599377A (en) | Traditional Chinese medicine for treating burn | |
| CN102920800A (en) | Topical drug composite and application and preparation method thereof | |
| CN101590125B (en) | Medicament for treating empyrosis and using method thereof | |
| CN101366846B (en) | External remedy for body surface burn, scald and ulcer | |
| CN1103596C (en) | Burn-treating medicine powder and its preparation | |
| CN104189332B (en) | Chinese medicine and preparation method thereof for treating scar | |
| CN113648382A (en) | Quick-acting composition for treating burns, scalds and infection and preparation method thereof | |
| CN114129622A (en) | Composition for treating burns and scalds, preparation method and application thereof | |
| CN103083373B (en) | Specific medicine for treating burns and scalds and other skin injury | |
| CN1172698C (en) | Chinese medicine for treating burn and scald and its preparing process | |
| CN103623007A (en) | Externally-applied ointment for treating ringworm of scalp and preparation and application methods thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110720 Termination date: 20121119 |